ID   PMC42
AC   CVCL_5215
SY   PMC-42; PMC42-ET; PMC-42 ET; PMC42ET
DR   GEO; GSM217595
DR   GEO; GSM1172988
DR   GEO; GSM3145729
DR   PharmacoDB; PMC42_1275_2019
DR   Progenetix; CVCL_5215
DR   Wikidata; Q54947618
RX   CelloPub=CLPUB00423;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2228321;
RX   PubMed=6381852;
RX   PubMed=6572752;
RX   PubMed=6606728;
RX   PubMed=11044355;
RX   PubMed=11161701;
RX   PubMed=24176112;
RX   PubMed=28889351;
WW   https://web.expasy.org/cellosaurus/pawefish/BreastCellLineDescriptions/pmc42.htm
WW   https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: GrayJW breast cancer cell line panel.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from metastatic site: Pleural effusion.
ST   Source(s): PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 7,9
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 23-06-22; Version: 21
//
RX   CelloPub=CLPUB00423;
RA   Morrison B.J.;
RT   "Breast cancer stem cells: tumourspheres and implications for therapy.";
RL   Thesis PhD (2010), Griffith University, Australia.
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994).
//
RX   PubMed=2228321; DOI=10.1002/ijc.2910460531;
RA   Monaghan P., Ormerod M.G., O'Hare M.J.;
RT   "Epidermal growth factor receptors and EGF-responsiveness of the human
RT   breast-carcinoma cell line PMC42.";
RL   Int. J. Cancer 46:935-943(1990).
//
RX   PubMed=6381852; DOI=10.1093/jnci/73.3.643;
RA   Whitehead R.H., Quirk S.J., Vitali A.A., Funder J.W., Sutherland R.L.,
RA   Murphy L.C.;
RT   "A new human breast carcinoma cell line (PMC42) with stem cell
RT   characteristics. III. Hormone receptor status and responsiveness.";
RL   J. Natl. Cancer Inst. 73:643-648(1984).
//
RX   PubMed=6572752; DOI=10.1093/jnci/70.4.649;
RA   Whitehead R.H., Bertoncello I., Webber L.M., Pedersen J.S.;
RT   "A new human breast carcinoma cell line (PMC42) with stem cell
RT   characteristics. I. Morphologic characterization.";
RL   J. Natl. Cancer Inst. 70:649-661(1983).
//
RX   PubMed=6606728; DOI=10.1093/jnci/71.6.1193;
RA   Whitehead R.H., Monaghan P., Webber L.M., Bertoncello I., Vitali A.A.;
RT   "A new human breast carcinoma cell line (PMC42) with stem cell
RT   characteristics. II. Characterization of cells growing as organoids.";
RL   J. Natl. Cancer Inst. 71:1193-1203(1983).
//
RX   PubMed=11044355; DOI=10.1054/bjoc.2000.1458;
RA   Davidson J.M., Gorringe K.L., Chin S.-F., Orsetti B., Besret C.,
RA   Courtay-Cahen C., Roberts I., Theillet C., Caldas C., Edwards P.A.W.;
RT   "Molecular cytogenetic analysis of breast cancer cell lines.";
RL   Br. J. Cancer 83:1309-1317(2000).
//
RX   PubMed=11161701; DOI=10.1006/excr.2000.5106;
RA   Ackland M.L., Michalczyk A., Whitehead R.H.;
RT   "PMC42, a novel model for the differentiated human breast.";
RL   Exp. Cell Res. 263:14-22(2001).
//
RX   PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110;
RA   Daemen A., Griffith O.L., Heiser L.M., Wang N.J., Enache O.M.,
RA   Sanborn Z., Pepin F., Durinck S., Korkola J.E., Griffith M., Hur J.S.,
RA   Huh N., Chung J., Cope L., Fackler M.J., Umbricht C., Sukumar S.,
RA   Seth P., Sukhatme V.P., Jakkula L.R., Lu Y.-L., Mills G.B., Cho R.J.,
RA   Collisson E.A., van 't Veer L.J., Spellman P.T., Gray J.W.;
RT   "Modeling precision treatment of breast cancer.";
RL   Genome Biol. 14:R110.1-R110.14(2013).
//
RX   PubMed=28889351; DOI=10.1007/s10549-017-4496-x;
RA   Saunus J.M., Smart C.E., Kutasovic J.R., Johnston R.L.,
RA   Kalita-de Croft P., Miranda M., Rozali E.N., Vargas A.C., Reid L.E.,
RA   Lorsy E., Cocciardi S., Seidens T., McCart Reed A.E., Dalley A.J.,
RA   Wockner L.F., Johnson J., Sarkar D., Askarian-Amiri M.E.,
RA   Simpson P.T., Khanna K.K., Chenevix-Trench G., Al-Ejeh F.,
RA   Lakhani S.R.;
RT   "Multidimensional phenotyping of breast cancer cell lines to guide
RT   preclinical research.";
RL   Breast Cancer Res. Treat. 167:289-301(2018).
//